Bortezomib
Catalog #
27028
$150
*
●
●
Purchase
Description
Potent (Ki, 0.6 nM), specific and reversible proteasome inhibitor; no significant inhibitory activity against other enzymes or receptors. Bortezomib inhibits cell proliferation of H460 cells (human non-small cell lung cancer cell lines) with an IC50 of 0.1 µM and has been associated with suppresion of prostate cancer cell lines with an IC90 of 10 nM.
●
Synonyms
Velcade, MG-341, PS-341
Product Info
Storage and Usage
Citations
Purity
≥99%
Format
White to off-white solid.
Formula
C19H25BN4O4
MW
384.2 Da
Solubility
Soluble in DMSO at 200 mg/ml; soluble in ethanol at 200 mg/ml; very poorly soluble in water; maximum solubility in plain water is estimated to be about 5-10 µM; buffers, serum, or other additives may increase or decrease the aqueous solubility.
CAS Registry #
179324-69-7
References
1. Bouchard, PR., et al. 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) & 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP (Eds.) (2004).
2. Ling, Y., et al. Clin. Cancer Res. 9: 1145-1154 (2003).
3. Williams, S., et al. Mol. Cancer Ther. 2: 835-843 (2003).
2. Ling, Y., et al. Clin. Cancer Res. 9: 1145-1154 (2003).
3. Williams, S., et al. Mol. Cancer Ther. 2: 835-843 (2003).